$22.27
0.65[3.01%]
Last update: 4:00PM Get Real Time Here
Silence Therapeutics
(NASDAQ:SLN)Silence Therapeutics Stock (NASDAQ:SLN), Earnings Estimates, EPS, and Revenue
Silence Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS
$-0.160
Quarterly Revenue
$2.6M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$25.4M
Analyze the earnings history of Silence Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | AM | SLN | Q1 | -$0.12 | — | — | — | $13.81M | — | — | — | Get Alert |
| 03/13/2024 | AM | SLN | Q4 | -$0.15 | — | -$0.16 | — | $5.59M | — | $2.61M | — | Get Alert |
| 11/14/2023 | AM | SLN | Q3 | -$0.08 | — | -$0.09 | — | $3.97M | — | $3.54M | — | Get Alert |
| 08/16/2023 | AM | SLN | Q2 | — | — | -$0.12 | — | $4.58M | — | $11.38M | — | Get Alert |
| 05/16/2023 | AM | SLN | Q1 | -$0.12 | — | -$0.12 | — | $7.68M | — | $13.81M | — | Get Alert |
| 03/15/2023 | AM | SLN | Q4 | -$0.14 | — | -$0.15 | — | $4.60M | — | $5.59M | — | Get Alert |
| 11/10/2022 | AM | SLN | Q3 | — | — | -$0.08 | — | — | — | $3.97M | — | Get Alert |
| 08/11/2022 | AM | SLN | Q2 | — | — | — | — | — | — | — | — | Get Alert |
| 05/16/2022 | AM | SLN | Q1 | — | — | -$0.12 | — | — | — | $7.68M | — | Get Alert |
| 03/17/2022 | AM | SLN | Q4 | — | — | -$0.14 | — | — | — | $4.60M | — | Get Alert |
FAQ
When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?
Silence Therapeutics (SLN) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on March 13, 2024 for Q4.
What were the latest earnings per share (EPS) for Silence Therapeutics (NASDAQ:SLN)?
The Actual EPS was $-0.16, which missed the estimate of $0.00.
What were Silence Therapeutics’s (NASDAQ:SLN) revenues?
The Actual Revenue was $2.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.